BRAIN Biotech AG (LON:0RFI)
2.300
-0.040 (-1.71%)
At close: Sep 17, 2025
BRAIN Biotech AG Revenue
BRAIN Biotech AG had revenue of 13.56M EUR in the quarter ending June 30, 2025, with 0.70% growth. This brings the company's revenue in the last twelve months to 53.61M, down -4.71% year-over-year. In the fiscal year ending September 30, 2024, BRAIN Biotech AG had annual revenue of 55.50M, down -1.29%.
Revenue (ttm)
53.61M EUR
Revenue Growth
-4.71%
P/S Ratio
0.90
Revenue / Employee
168.59K EUR
Employees
318
Market Cap
41.31M GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Sep 30, 2024 | 55.50M | -726.00K | -1.29% |
Sep 30, 2023 | 56.23M | 5.93M | 11.79% |
Sep 30, 2022 | 50.30M | 11.07M | 28.23% |
Sep 30, 2021 | 39.22M | 158.00K | 0.40% |
Sep 30, 2020 | 39.06M | -982.00K | -2.45% |
Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sep 30, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 41.24B |
HSBC Holdings | 41.03B |
Shell | 198.54B |
Unilever | 51.24B |
Rolls-Royce Holdings | 19.54B |
British American Tobacco p.l.c. | 25.60B |
Rio Tinto Group | 39.22B |
BP p.l.c. | 134.89B |